Begin main content

Reslizumab

Last Updated: May 4, 2016
Result type: Reports
Project Number: SR0495-000
Product Line: Common Drug Review

Generic Name: Reslizumab

Brand Name: Cinqair

Manufacturer: TEVA Canada Innovation

Indications: Asthma, eosinophilic

Submission Type: New

Project Status: Complete

Date Recommendation Issued: March 22, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions